256 related articles for article (PubMed ID: 22391922)
1. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer.
Gambini V; Tilio M; Maina EW; Andreani C; Bartolacci C; Wang J; Iezzi M; Ferraro S; Ramadori AT; Simon OC; Pucciarelli S; Wu G; Dou QP; Marchini C; Galassi R; Amici A
Eur J Med Chem; 2018 Jul; 155():418-427. PubMed ID: 29906688
[TBL] [Abstract][Full Text] [Related]
3. A study on the inhibition of dihydrofolate reductase (DHFR) from Escherichia coli by gold(i) phosphane compounds. X-ray crystal structures of (4,5-dichloro-1H-imidazolate-1-yl)-triphenylphosphane-gold(i) and (4,5-dicyano-1H-imidazolate-1-yl)-triphenylphosphane-gold(i).
Galassi R; Oumarou CS; Burini A; Dolmella A; Micozzi D; Vincenzetti S; Pucciarelli S
Dalton Trans; 2015 Feb; 44(7):3043-56. PubMed ID: 25567238
[TBL] [Abstract][Full Text] [Related]
4. Gold(I) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents.
Serebryanskaya TV; Lyakhov AS; Ivashkevich LS; Schur J; Frias C; Prokop A; Ott I
Dalton Trans; 2015 Jan; 44(3):1161-9. PubMed ID: 25413270
[TBL] [Abstract][Full Text] [Related]
5. Alkynyl gold(I) phosphane complexes: Evaluation of structure-activity-relationships for the phosphane ligands, effects on key signaling proteins and preliminary in-vivo studies with a nanoformulated complex.
Andermark V; Göke K; Kokoschka M; Abu El Maaty MA; Lum CT; Zou T; Sun RW; Aguiló E; Oehninger L; Rodríguez L; Bunjes H; Wölfl S; Che CM; Ott I
J Inorg Biochem; 2016 Jul; 160():140-8. PubMed ID: 26850306
[TBL] [Abstract][Full Text] [Related]
6. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
[TBL] [Abstract][Full Text] [Related]
7. Luminescent alkynyl-gold(I) coumarin derivatives and their biological activity.
Arcau J; Andermark V; Aguiló E; Gandioso A; Moro A; Cetina M; Lima JC; Rissanen K; Ott I; Rodríguez L
Dalton Trans; 2014 Mar; 43(11):4426-36. PubMed ID: 24302256
[TBL] [Abstract][Full Text] [Related]
8. Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases.
Urig S; Fritz-Wolf K; Réau R; Herold-Mende C; Tóth K; Davioud-Charvet E; Becker K
Angew Chem Int Ed Engl; 2006 Mar; 45(12):1881-6. PubMed ID: 16493712
[No Abstract] [Full Text] [Related]
9. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
[TBL] [Abstract][Full Text] [Related]
10. Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties.
Srinivasa Reddy T; Privér SH; Rao VV; Mirzadeh N; Bhargava SK
Dalton Trans; 2018 Nov; 47(43):15312-15323. PubMed ID: 30187047
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the antitumoral activity of phosphine-thiosemicarbazone gold(I) complexes obtained by different methodologies.
González-Barcia LM; Fernández-Fariña S; Rodríguez-Silva L; Bermejo MR; González-Noya AM; Pedrido R
J Inorg Biochem; 2020 Feb; 203():110931. PubMed ID: 31786438
[TBL] [Abstract][Full Text] [Related]
12. Gold(I) complexes of water-soluble diphos-type ligands: synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition.
Wetzel C; Kunz PC; Kassack MU; Hamacher A; Böhler P; Watjen W; Ott I; Rubbiani R; Spingler B
Dalton Trans; 2011 Sep; 40(36):9212-20. PubMed ID: 21826354
[TBL] [Abstract][Full Text] [Related]
13. Imidazole-based phosphane gold(I) complexes as potential agents for cancer treatment: synthesis, structural studies and antitumour activity.
Kunz PC; Kassack MU; Hamacher A; Spingler B
Dalton Trans; 2009 Oct; (37):7741-7. PubMed ID: 19759948
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches.
Karaca Ö; Scalcon V; Meier-Menches SM; Bonsignore R; Brouwer JMJL; Tonolo F; Folda A; Rigobello MP; Kühn FE; Casini A
Inorg Chem; 2017 Nov; 56(22):14237-14250. PubMed ID: 29095609
[TBL] [Abstract][Full Text] [Related]
15. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
Liu W; Bensdorf K; Proetto M; Abram U; Hagenbach A; Gust R
J Med Chem; 2011 Dec; 54(24):8605-15. PubMed ID: 22091836
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF
J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390
[TBL] [Abstract][Full Text] [Related]
17. Cobaltoceniumethynyl gold(I) as an unusual heterodinuclear bioorganometallic fragment to study the biological properties of alkynyl gold complexes.
Vanicek S; Kopacka H; Wurst K; Vergeiner S; Kankowski S; Schur J; Bildstein B; Ott I
Dalton Trans; 2016 Jan; 45(4):1345-8. PubMed ID: 26732365
[TBL] [Abstract][Full Text] [Related]
18. Anticancer therapeutics that target selenoenzymes: synthesis, characterization, in vitro cytotoxicity, and thioredoxin reductase inhibition of a series of gold(I) complexes containing hydrophilic phosphine ligands.
Vergara E; Casini A; Sorrentino F; Zava O; Cerrada E; Rigobello MP; Bindoli A; Laguna M; Dyson PJ
ChemMedChem; 2010 Jan; 5(1):96-102. PubMed ID: 19937669
[TBL] [Abstract][Full Text] [Related]
19. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
Li CK; Sun RW; Kui SC; Zhu N; Che CM
Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
[TBL] [Abstract][Full Text] [Related]
20. New cyclometalated gold (III) complex targeting thioredoxin reductase: exploring as cytotoxic agents and mechanistic insights.
Abyar F; Tabrizi L
Biometals; 2020 Jun; 33(2-3):107-122. PubMed ID: 32246384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]